Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Thrombocytopenia is associated with adverse outcomes following treatment with either enoxaparin or unfractionated heparin in patients presenting with acute coronary syndromes: a TIMI 11B substudy

Thrombocytopenia is associated with adverse outcomes following treatment with either enoxaparin or unfractionated heparin in patients presenting with acute coronary syndromes: a TIMI 11B substudy. Journal of the American College of Cardiology. 2006; 47(Suppl1):207A.


Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.